We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
51
Salesforce
CRM
$158B
$452M 0.37%
2,141,432
+46,238
+2% +$9.44M
MTUM icon
52
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
$421M 0.35%
2,919,685
+89,212
+3% +$12.5M
USHY icon
53
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.7B
$414M 0.34%
11,730,255
+398,475
+4% +$14M
RTX icon
54
RTX Corp
RTX
$301B
$414M 0.34%
4,223,521
+20,532
+0.5% +$2.01M
SMMV icon
55
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$292M
$402M 0.33%
11,723,728
+358,552
+3% +$12.3M
ORCL icon
56
Oracle
ORCL
$423B
$400M 0.33%
3,356,627
-288,637
-8% -$29.8M
PEP icon
57
PepsiCo
PEP
$190B
$390M 0.32%
2,105,256
-8,831
-0.4% -$1.65M
DVN icon
58
Devon Energy
DVN
$47.3B
$388M 0.32%
8,027,615
+350,916
+5% +$17.6M
MCD icon
59
McDonald's
MCD
$195B
$387M 0.32%
1,296,043
+6,105
+0.5% +$1.77M
LLY icon
60
Eli Lilly
LLY
$1.06T
$384M 0.32%
819,633
+65,262
+9% +$27.4M
VYM icon
61
Vanguard High Dividend Yield ETF
VYM
$82.8B
$366M 0.3%
3,450,215
-433,525
-11% -$45.5M
VIG icon
62
Vanguard Dividend Appreciation ETF
VIG
$114B
$339M 0.28%
2,087,027
-60,414
-3% -$9.46M
ACN icon
63
Accenture
ACN
$108B
$332M 0.27%
1,076,053
+88,744
+9% +$25.8M
QCOM icon
64
Qualcomm
QCOM
$176B
$332M 0.27%
2,787,657
-19,162
-0.7% -$2.2M
XLP icon
65
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$329M 0.27%
4,433,886
+228,935
+5% +$17.2M
ABT icon
66
Abbott
ABT
$187B
$327M 0.27%
3,002,279
+8,422
+0.3% +$898K
VEU icon
67
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$326M 0.27%
5,999,539
+48,658
+0.8% +$2.64M
PFE icon
68
Pfizer
PFE
$153B
$321M 0.26%
8,744,401
-109,770
-1% -$4.27M
NEE icon
69
NextEra Energy
NEE
$177B
$316M 0.26%
4,252,066
-309,697
-7% -$23.4M
XOM icon
70
ExxonMobil
XOM
$634B
$312M 0.26%
2,905,099
+142,448
+5% +$15.5M
SPGI icon
71
S&P Global
SPGI
$120B
$308M 0.25%
769,518
+21,318
+3% +$7.79M
VTV icon
72
Vanguard Morningstar Value ETF
VTV
$191B
$303M 0.25%
2,132,622
-71,552
-3% -$9.94M
ADBE icon
73
Adobe
ADBE
$105B
$299M 0.25%
612,121
+29,779
+5% +$12M
DRI icon
74
Darden Restaurants
DRI
$24.4B
$296M 0.24%
1,770,027
+82,295
+5% +$12.9M
DHR icon
75
Danaher
DHR
$144B
$295M 0.24%
1,388,031
+2,808
+0.2% +$594K

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.